Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pancreatic Cyst 1Multiple Endocrine Neoplasia Type 1 1Gliosarcoma 1Glioblastoma 1Depression 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Alcoholism 1

Interventions

Psilocybin 6Therapeutics 2Ketamine 2Exercise 2Venlafaxine Hydrochloride 1Vegetables 1Terminal Care 1Self-Management 1SLI381 1Psychotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Professional Autonomy 1Niacin 1Mirtazapine 1Minocycline 1Methylphenidate 1Mental Status and Dementia Tests 1Melatonin 1Medical Marijuana 1Interpersonal Psychotherapy 1Injections 1Infliximab 1Gemcitabine 1Fruit 1Fluoxetine 1Ethanol 1Doxorubicin 1Donepezil 1Dignity Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Depression × Ethanol × Clear all
NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡